Exploring treatment of inflammatory bowel disease with infliximab in the Middle East and Northern Africa: An analysis of the HARIR observational cohort study

Exploring treatment of inflammatory bowel disease with infliximab in the Middle East and Northern Africa: An analysis of the HARIR observational cohort study

Background: In 2017, inflammatory bowel disease, including Crohn's disease (CD) and ulcerative colitis (UC) affected more than 6.8 million people worldwide, with increased incidence in newly industrialized countries. Although treatment options were previously limited to symptom reduction, curr...

Full description

Bibliographic Details
Main Authors: Othman Alharbi, Waleed Hamed, Osama Salem, Catherine Taylor, Ahmed Besar, Mohamed Sharaf
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
crohn's disease
infliximab
ulcerative colitis
inflammatory bowel disease
biologics
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2023;volume=29;issue=3;spage=164;epage=170;aulast=

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2023;volume=29;issue=3;spage=164;epage=170;aulast=

Similar Items